Glipizide

insulin ; Homo sapiens







94 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 2663691 The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus. 1989 Mar 2
52 2772334 [Glipizide in the treatment of non-insulin-dependent diabetes mellitus]. 1989 Jun 1
53 3047519 The effect of glipizide on extraction of insulin by the human cirrhotic and noncirrhotic liver. 1988 Sep 3
54 3065086 The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia. 1988 2
55 3126626 Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy. 1988 1
56 3277013 Atherosclerosis in diabetes: the role of hyperinsulinemia. 1988 Feb 1
57 2956042 Treatment of patients with non-insulin-dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities. 1987 Jul-Aug 1
58 3117609 Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. 1987 Nov 3
59 3123184 Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. 1987 Nov-Dec 3
60 3307402 Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus. 1987 Sep 18 2
61 3307403 Effects of short-term insulin therapy upon therapeutic response to glipizide. 1987 Sep 18 2
62 3307404 Achieving therapeutic goals in insulin-using diabetic patients with non-insulin-dependent diabetes mellitus. A weight reduction-exercise-oral agent approach. 1987 Sep 18 1
63 3318259 The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. 1987 Nov 3
64 3319648 Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion. 1987 1
65 2429808 Effect of glipizide on insulin secretion from cultured human fetal pancreatic islets. 1986 Sep-Oct 1
66 3530592 Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes. 1986 Jul 4
67 3923454 Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use. 1985 Mar-Apr 1
68 6376145 Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. 1984 6
69 6392057 Insulin binding on MOLT 4 cells: effect of a sulfonylurea. 1984 1
70 6341263 Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers. 1983 Feb 2
71 6369967 Mechanism of action of the second-generation sulfonylurea glipizide. 1983 Nov 30 4
72 6369969 Long-term safety and efficacy of glipizide. 1983 Nov 30 1
73 6369970 Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus. 1983 Nov 30 4
74 6369972 Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus. 1983 Nov 30 1
75 6754633 Glipizide pharmacokinetics and response in diabetics. 1982 Sep 2
76 6759246 Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. 1982 Apr 2
77 6765225 Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes. 1982 Sep-Oct 1
78 7047169 Influence of sulfonylureas on the secretion, disposal and effect of insulin. 1982 1
79 7051722 Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus. 1982 Jul 1
80 7027714 Forearm insulin uptake in healthy subjects after oral glucose and intravenous glipizide. 1981 Nov 5
81 7046346 Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide. 1981 4
82 6776763 Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics. 1980 2
83 6778079 Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers. 1980 2
84 6988265 Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations. 1980 Jan 3
85 6990184 Sulfonylurea treatment of insulin-independent diabetes mellitus. 1980 May 1
86 7001839 Influence of glipizide on hepatic and peripheral insulin exchange after glucose administration. 1980 1
87 7002565 Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. 1980 Oct 3
88 371340 Insulin in portal, hepatic and peripheral venous blood after glucose, tolbutamide and glipizide stimulation. Indication of insulin release from peripheral tissues. 1979 1
89 396109 Plasma levels of glucose and lactate after intravenous glipizide administration in some insulin-dependent diabetics. Therapeutic effects of an associated glipizide-insulin treatment. 1979 2
90 345754 Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. 1978 1
91 860916 [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration]. 1977 Jan-Mar 1
92 903405 Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. 1977 Sep 2
93 1258487 [The effect of Glipizide on the blood glucose and insulin in non-ketotic diabetes mellitus (author's transl)]. 1976 Jan 23 1
94 4469884 [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects]. 1974 Nov 1